Physician's Weekly Podcast

Novel HER2 low therapy; kidney cancer awareness; RT insight on COVID; malpractice video evidence

June 25, 2021 Physician's Weekly Season 1 Episode 19
Physician's Weekly Podcast
Novel HER2 low therapy; kidney cancer awareness; RT insight on COVID; malpractice video evidence
Show Notes Chapter Markers

This week's thought leaders include:

  • Sara Hurvitz, MD, UCLA Jonsson Comprehensive Cancer Center
  • Brady Scott, PhD, Respiratory Care at Rush University 
  • Sallie McAdoo, Director of the Kidney Cancer Association
  • Dr. Medlaw, MD, JD, medical malpractice attorney, board certified radiologist


In a landmark case, a US jury has found a former police officer Derek Chauvin guilty of murder over the death of African-American George Floyd. From the medical point of view, one interesting and controversial aspect of this trial was of use of a video as evidence to prove the cause of death.

In this episode of the Physician’s Weekly Podcast, we spoke with our regular expert contributor with the pseudonym Dr. Medlaw about how videos can provide medical evidence for the murder of George Floyd.

Also in this episode, we interview Dr. Brady Scott, Associate Professor in the Division of Respiratory Care at Rush University about Lessons learned in critical care / respiratory care during the COVID-19 pandemic.

Medical Oncologist Sara Hurvitz, MD, at the UCLA Jonsson Comprehensive Cancer Center discusses a new clinical trial she is involved with taking a novel approach to treat breast cancer patients.

But first we talk with the medical director of the Kidney Cancer Association, Sallie McAdoo, about the need for kidney cancer awareness in honor of World Kidney Cancer Day on June 17th, 2021.


Let us know what you thought of this week’s episode on Twitter: @physicianswkly

Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com!

Thanks for listening!

World Kidney Cancer Day
Lessons Learned in the ER from COVID-19
TALENT trial: Novel treatment of HER2 low
Video evidence in a Malpractice Case